^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Bladder Cancer
    Drug:cisplatin (DNA synthesis inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    Source:
    FDA
    Published date:
    02/22/2019
    Excerpt:
    Cisplatin for injection is a platinum-based drug indicated for the treatment of...Advanced bladder cancer.
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    NCCN Recommendations for treatment of Muscle-Invasive Bladder Cancer…The following radiosensitizing regimens are recommended: cisplatin plus 5-FU; cisplatin plus paclitaxel; 5-FU plus mitomycin C; and cisplatin alone.